NovoRapid (insulin aspart), a new rapid-acting insulin analog

Novo Nordisk is now marketing NovoRapid (insulin aspart), a new rapid-acting insulin analog.

It's available in the U.S. under the brand name Novolog.

NovoRapid is similar to Humalog (insulin lispro).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote